Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.66 USD | -0.60% |
|
-12.63% | -10.27% |
07/06 | Chardan Research Initiates Cognition Therapeutics With Buy Rating, $11 Price Target | MT |
29/05 | HC Wainwright Starts Cognition Therapeutics With Buy Rating, $10 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.27% | 6.65Cr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-19.03% | 1.59TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr |
- Stock Market
- Equities
- CGTX Stock
- News Cognition Therapeutics, Inc.
- B. Riley Starts Cognition Therapeutics at Buy with $27 PT, Notes Conviction in Proprietary, Mid-Stage Pipeline